These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 17881621)

  • 1. Do HMOs reduce preventable hospitalizations for Medicare beneficiaries?
    Basu J; Mobley LR
    Med Care Res Rev; 2007 Oct; 64(5):544-67. PubMed ID: 17881621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of medicare health maintenance organizations on hospitalization rates for ambulatory care-sensitive conditions.
    Zeng F; O'Leary JF; Sloss EM; Lopez MS; Dhanani N; Melnick G
    Med Care; 2006 Oct; 44(10):900-7. PubMed ID: 17001260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare HMOs: who joins and who leaves?
    Virnig BA; Morgan RO; DeVito CA; Persily NA
    Am J Manag Care; 1998 Apr; 4(4):511-8. PubMed ID: 10179910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conducting research on the Medicare market: the need for better data and methods.
    Wong HS; Hellinger FJ
    Health Serv Res; 2001 Apr; 36(1 Pt 2):291-308. PubMed ID: 11327178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing mortality and time until death for medicare HMO and FFS beneficiaries.
    Maciejewski ML; Dowd B; Call KT; Feldman R
    Health Serv Res; 2001 Feb; 35(6):1245-65. PubMed ID: 11221818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managed care and preventable hospitalization among Medicaid adults.
    Basu J; Friedman B; Burstin H
    Health Serv Res; 2004 Jun; 39(3):489-510. PubMed ID: 15149475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events for hospitalized medicare patients: is there a difference between HMO and FFS enrollees?
    Basu J; Friedman B
    Soc Work Public Health; 2013; 28(7):639-51. PubMed ID: 24074128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare HMO impact on utilization at the end of life.
    Fonkych K; O'Leary JF; Melnick GA; Keeler EB
    Am J Manag Care; 2008 Aug; 14(8):505-12. PubMed ID: 18690766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Medicare-HMO revolving door--the healthy go in and the sick go out.
    Morgan RO; Virnig BA; DeVito CA; Persily NA
    N Engl J Med; 1997 Jul; 337(3):169-75. PubMed ID: 9219704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare managed care plan performance: a comparison across hospitalization types.
    Basu J; Mobley LR
    Medicare Medicaid Res Rev; 2012; 2(1):. PubMed ID: 24800137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare Advantage and the impact of Medicare HMOs on inpatient utilization.
    Minott J
    Find Brief; 2007 Oct; 10(9):1-3. PubMed ID: 18019951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare HMO disenrollment and selective use of medical care: osteoarthritis-related joint replacement.
    Morgan RO; Virnig BA; DeVito CA; Persily NA
    Am J Manag Care; 2000 Aug; 6(8):917-23. PubMed ID: 11186503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year changes in health and functional status among elderly Medicare beneficiaries in HMOs and fee-for-service.
    Riley G
    Health Serv Res; 2000 Dec; 35(5 Pt 3):44-59. PubMed ID: 16148951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients.
    Potosky AL; Merrill RM; Riley GF; Taplin SH; Barlow W; Fireman BH; Lubitz JD
    Health Serv Res; 1999 Jun; 34(2):525-46. PubMed ID: 10357289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discretionary hospital use and diagnostic risk adjustment of Medicare HMO capitation rates.
    Porell FW; Gruenberg L
    Inquiry; 2000; 37(2):162-72. PubMed ID: 10985110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How the elderly fare in HMOs: outcomes from the Medicare competition demonstrations.
    Retchin SM; Clement DG; Rossiter LF; Brown B; Brown R; Nelson L
    Health Serv Res; 1992 Dec; 27(5):651-69. PubMed ID: 1464538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inpatient utilization by dual Medicare-Medicaid eligibles in Medicare risk HMOs and fee for service, California, 1991-1996.
    Sloss EM; Dhanani N; O'Leary JF; Lopez MS; Melnick G
    Manag Care Interface; 2004 Dec; 17(12):30-4, 41. PubMed ID: 15656377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-level cost of home health care under capitated and fee-for-service payment.
    Schlenker RE; Shaughnessy PW; Hittle DF
    Inquiry; 1995; 32(3):252-70. PubMed ID: 7591040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of Medicare fee-for-service and a group-model HMO in the inpatient management and long-term survival of elderly individuals with syncope.
    Getchell WS; Larsen GC; Morris CD; McAnulty JH
    Am J Manag Care; 2000 Oct; 6(10):1089-98. PubMed ID: 11184665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of Medicare health care delivery systems with stage at diagnosis and survival for patients with melanoma.
    Kirsner RS; Wilkinson JD; Ma F; Pacheco H; Federman DG
    Arch Dermatol; 2005 Jun; 141(6):753-7. PubMed ID: 15967922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.